101931-00-4,
Hydroxy Pioglitazone (M-II) (Mixture of Diastereomers),
HYDROXY PIOGLITAZONE (M-II),
5-(4-(2-(5-ethylpyridin-2-yl)-2-hydroxyethoxy)benzyl)thiazolidine-2,4-dione,
5-[[4-[2-(5-ETHYL-2-PYRIDINYL)-2-HYDROXYETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE,
5-((4-(2-(5-Ethyl-2-pyridinyl)-2-hydroxyethoxy)phenyl)methyl)-2,4-thiazolidinedione,
5-[[4-[2-(5-Ethyl-2-pyridinyl]-2-hydroxyethoxy]phenyl]methyl]-2,4-thiazolidinedione,
5-[4-[2-(5-ethyl-2-pyridyl)-2-hydroxyethoxy]benzyl]-2,4-thiazolidinedione,
5-{4-[2-(5-ethyl-2-pyridyl)-2-hydroxyethoxy]benzyl}-2,4-thiazolidinedione,
RMTFRGFLVHAYCI-UHFFFAOYSA-N,
2-Hydroxypioglitazone,
CHEMBL1270,
SCHEMBL2327405,
CTK6D1829,
DTXSID20432066,
RT-013276,
FT-0670013,
Hydroxy Pioglitazone-d4 (M-II) (deuterated),
U-90760,
J-000524,
2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)-2-hydroxyethoxy)phenyl)methyl)-,
5-({p-[2-(5-ethylpyridin-2-yl)-2-hydroxyethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione,
UNII-M77TY40AOT,
M77TY40AOT,
CID9864268,
5-[[4-[2-(5-ethylpyridin-2-yl)-2-hydroxy-ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,